Barostim and the Window of Opportunity in Class II/III HFrEF Patients THT 2024 Discussion

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Barostim and the Window of Opportunity in Class II/III HFrEF Patients THT 2024 Discussion

By CVRx | Barostim FEATURING Gurusher Panjrath, Dmitry Yaranov, JoAnn Lindenfeld, J. Thomas Heywood

24 views

April 24, 2024

Hear discussion and insights from Drs. J. Thomas Heywood, JoAnn Lindenfeld, Gurusher Panjrath, and Dmitry Yaranov following the THT 2024 symposium.

0 Comments

Patient Identification and Post-Implant Management within an Advance…

Feat. D. Yaranov